Kelley Shaffer, PA
Medical · Burleson, TXNPI 1538782677
Payments from drug & device makers
Across 254 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$611
- AstraZeneca$525
- Novo Nordisk$433
- Lilly USA, LLC$429
- Boehringer Ingelheim$242
- Astellas Pharma US Inc$222
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,448100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $611 |
| AstraZeneca | 24 | $525 |
| Novo Nordisk | 26 | $433 |
| Lilly USA, LLC | 26 | $429 |
| Boehringer Ingelheim | 14 | $242 |
| Astellas Pharma US Inc | 11 | $222 |
| Pfizer | 11 | $214 |
| GSK | 11 | $181 |
| Otsuka America Pharmaceutical, Inc. | 9 | $170 |
| Abbott | 8 | $159 |
| Biohaven Pharmaceuticals, Inc. | 3 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $108 |
| Sanofi-aventis U.S. LLC | 5 | $99 |
| Esperion Therapeutics, Inc. | 5 | $95 |
| Amgen | 6 | $92 |
| Biogen | 4 | $86 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $84 |
| Antares Pharma, Inc. | 4 | $70 |
| Lundbeck LLC | 3 | $67 |
| Novartis | 4 | $65 |
| Bayer | 3 | $61 |
| Indivior Inc. | 3 | $60 |
| Exact Sciences | 3 | $55 |
| Vanda Pharmaceuticals Inc. | 2 | $32 |
| Corium, LLC | 1 | $26 |
| Dexcom, Inc. | 1 | $22 |
| Orexo US, Inc. | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $18 |
| Dynavax Technologies Corporation | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Impel Pharmaceuticals Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
How this compares
$4,468 in reported general payments places this provider in the 80th percentile of 1,490 medical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 21 | $23,920 |
| OzempicSemaglutide | 17 | $22,215 |
| EliquisApixaban | 18 | $18,630 |
| MounjaroTirzepatide | 13 | $17,363 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $16,930 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $14,111 |
| LinzessLinaclotide | 12 | $9,078 |
| Gabapentin | 43 | $972 |
| Atorvastatin Calcium | 131 | $965 |
| Bupropion XlBupropion Hcl | 33 | $813 |
| Omeprazole | 34 | $783 |
| Rosuvastatin Calcium | 84 | $742 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $720 |
| Levothyroxine Sodium | 88 | $695 |
| FenofibrateFenofibrate Nanocrystallized | 12 | $563 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $242 | $23,92021 claims |
| Novo NordiskOzempic | $433 | $22,21517 claims |
| PfizerEliquis | $214 | $18,63018 claims |
| Lilly USA, LLCMounjaro | $429 | $17,36313 claims |
| GSKTrelegy Ellipta | $181 | $16,93023 claims |
| AstraZenecaBreztri Aerosphere | $525 | $14,11113 claims |
| AbbVieLinzess | $611 | $9,07812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,490 medical providers in Texas.
Other medical in Burleson
- Stephanie NguyenBurleson$17K
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Courtney AldridgeSan Antonio$129K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.